K. Brunnert

Radiation therapy after breast-conserving surgery

Klaus Winzer, Rolf Sauer, Willi Sauerbrei et al. · European Journal of Cancer · 2004 · 77 citations · Full text

Surgical Oncology, Radiation Therapy, Medicine +6

Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer.

M. Kaufmann, W. Jonat, Ulrich Abel et al. · Journal of Clinical Oncology · 1993 · 54 citations

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: A randomised trial (GABG trial IV-A-93)

Gϋnter von Minckwitz, Erika Graf, Matthias Geberth et al. · European Journal of Cancer · 2006 · 44 citations

Breast Oncology, Oncology, Cmf Versus Goserelin +8

Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer—a multicentre, open, controlled, prospectively randomised trial

Gϋnter von Minckwitz, Sibylle Loibl, K. Brunnert et al. · European Journal of Cancer · 2002 · 44 citations

Adjuvant Endocrine Treatment, Medroxyprogesterone Acetate, Endocrine Oncology +7

A Retrospective Head-to-head Comparison Between TiLoop Bra/TiMesh® and Seragyn® in 320 Cases of Reconstructive Breast Surgery

Christian Eichler, Carolin Schulz, Fabinshy Thangarajah et al. · Anticancer Research · 2019 · 36 citations · Full text